Illustrating Alchemy, 18th Century

As the science of chemistry developed, public perceptions of alchemists shifted from respect to ridicule.

Written byJyoti Madhusoodanan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FROM RICHES TO RAGS: The Medical Alchemist, an 18th-century oil painting on copper by Franz Christoph Janneck, depicts a urinalysis scene. Painted during a period when European society transitioned from revering alchemists as legitimate medical practitioners to viewing them as quacks, the piece appears to reflect this latter opinion. The frayed Turkish carpet on the alchemist’s table hints at poverty. His cap—a traditional physician’s hat—sits askew on his balding head, his stocking droops, and the glasses he wears make his eyes appear almost comical. GIFT OF FISHER SCIENCE INTERNATIONAL. CHEMICAL HERITAGE FOUNDATION COLLECTIONS. PHOTOGRAPH BY WILL BROWN. During the Middle Ages, European alchemists, in addition to their quest to transform common metals into gold, often acted as physicians and pharmacists. They diagnosed diseases and concocted cures from herbs and minerals using techniques such as distillation and metallurgy, methods familiar to modern-day scientists.

Early pictorial representations of their work as healers were restricted to alchemical texts and manuals. Over time, artists began to depict them in paintings, such as The Medical Alchemist (see image), an archetypal 18th-century piece by Austrian artist Franz Christoph Janneck, in which an alchemist plays physician, peering up at a urine sample.

Tests of urine—analyzing the color, smell, sediments, or even the taste—were frequently used at the time to diagnose medical conditions. In this painting, the patient, or a maid who delivered the sample, waits for the results, while the alchemist’s assistant keeps a flame going under the distillation apparatus. He’s surrounded by the tools of his trade: herbs dangle from the rafters; a mortar and pestle and a manuscript with alchemical symbols lie ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies